Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$98.98 - $115.74 $9.42 Million - $11 Million
-95,215 Reduced 35.48%
173,122 $20 Million
Q2 2023

Aug 11, 2023

SELL
$96.34 - $112.38 $6.07 Million - $7.08 Million
-62,987 Reduced 19.01%
268,337 $27.6 Million
Q1 2023

May 12, 2023

SELL
$107.32 - $113.5 $39.6 Million - $41.9 Million
-368,842 Reduced 52.68%
331,324 $36.2 Million
Q4 2022

Feb 13, 2023

SELL
$62.39 - $113.8 $51.1 Million - $93.2 Million
-818,874 Reduced 53.91%
700,166 $79.7 Million
Q3 2022

Nov 15, 2022

BUY
$58.92 - $84.67 $61.2 Million - $87.9 Million
1,038,577 Added 216.16%
1,519,040 $94 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $8.43 Million - $12.4 Million
106,156 Added 28.36%
480,463 $38.3 Million
Q1 2022

May 13, 2022

BUY
$86.42 - $109.81 $2.54 Million - $3.23 Million
29,377 Added 8.52%
374,307 $39.3 Million
Q4 2021

Feb 11, 2022

SELL
$98.56 - $119.91 $9.11 Million - $11.1 Million
-92,389 Reduced 21.13%
344,930 $37.1 Million
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $9,282 - $11,147
101 Added 0.02%
437,319 $47.8 Million
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $520,372 - $578,781
6,034 Added 1.4%
437,218 $40.9 Million
Q1 2021

May 13, 2021

SELL
$71.83 - $95.48 $1.28 Million - $1.7 Million
-17,799 Reduced 3.96%
431,184 $39.6 Million
Q4 2020

Feb 10, 2021

BUY
$67.0 - $84.39 $6.83 Million - $8.6 Million
101,930 Added 29.37%
448,983 $32.8 Million
Q3 2020

Nov 12, 2020

BUY
$55.23 - $79.93 $4.93 Million - $7.14 Million
89,303 Added 34.65%
347,053 $27 Million
Q2 2020

Aug 13, 2020

BUY
$30.2 - $56.98 $5.37 Million - $10.1 Million
177,750 Added 222.19%
257,750 $14.3 Million
Q1 2020

May 14, 2020

BUY
$24.87 - $38.56 $176,577 - $273,776
7,100 Added 9.74%
80,000 $2.37 Million
Q3 2019

Nov 13, 2019

BUY
$23.0 - $27.97 $1.68 Million - $2.04 Million
72,900 New
72,900 $1.99 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.